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OBJECTIVE— To determine the concurrent, prospective, and time-concordant relation-
ships among major depressive disorder (MDD), depressive symptoms, and diabetes distress with
glycemic control.
RESEARCH DESIGN AND METHODS— In a noninterventional study, we assessed
506 type 2 diabetic patients for MDD (Composite International Diagnostic Interview), for de-
pressive symptoms (Center for Epidemiological Studies-Depression), and for diabetes distress
(Diabetes Distress Scale), along with self-management, stress, demographics, and diabetes status,
at baseline and 9 and 18 months later. Using multilevel modeling (MLM), we explored the
cross-sectional relationships of the three affective variables with A1C, the prospective relation-
ships of baseline variables with change in A1C over time, and the time-concordant relationships
with A1C.
RESULTS— All three affective variables were moderately intercorrelated, although the rela-
tionship between depressive symptoms and diabetes distress was greater than the relationship of
either with MDD. In the cross-sectional MLM, only diabetes distress but not MDD or depressive
symptoms was significantly associated with A1C. None of the three affective variables were
linked with A1C in prospective analyses. Only diabetes distress displayed significant time-
concordant relationships with A1C.
CONCLUSIONS— We found no concurrent or longitudinal association between MDD or
depressive symptoms with A1C, whereas both concurrent and time-concordant relationships
were found between diabetes distress and A1C. What has been called “depression” among type
2 diabetic patients may really be two conditions, MDD and diabetes distress, with only the latter
displaying significant associations with A1C. Ongoing evaluation of both diabetes distress and
MDD may be helpful in clinical settings.
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C linical depression, depressive affect,and diabetes distress are prevalentemotional states found among pa-
tients with diabetes (1). These states are
associated with high morbidity and mor-
tality (2,3). One line of research has ex-
plored whether depression is a risk factor
for diabetes or whether diabetes is a risk
factor for depression. There are substan-
tive data to suggest that depression is in-
deed a risk factor for subsequent diabetes
(4) and that there may be a bidirectional
relationship between depression and dia-
betes over time (5). A second line of re-
search has explored the linkages between
depression and glycemic control among
patients who already have diabetes. Here
the findings are less clear. In a landmark
study published in 2000, Lustman et al.
(6) presented a meta-analysis of the liter-
ature on depression and glucose control
among patients who already have diabe-
tes and reported a modest but significant
effect size (d 0.19). They raised several
cautions about interpreting their results,
however, because of concerns that some
previous studies mixed type 1 and type 2
diabetic patients, used symptom mea-
sures that were not tied to defined diag-
noses, were primarily cross-sectional, and
lacked appropriate demographic and life-
style controls. Subsequent studies of de-
pression and glycemic control among
patients who already have diabetes also
have yielded mixed findings, and Geor-
giades et al. (7) recently listed 7 studies
that demonstrated a significant relation-
ship and 10 that did not. Furthermore,
intervention trials to reduce depression
among patients with diabetes have not
consistently led to corresponding reduc-
tions in A1C or to improvements in self-
care behavior (8,9), and trials to improve
diabetes self-care and glycemic control
have not consistently led to a reduction
in depression (10). Consequently, the
causal linkages and pathways between
depression and glycemic control among
patients who already have diabetes are
well studied but unclear.
Two major factors that contribute to
this lack of clarity concern problems of
definition and related measurement. De-
pression among patients with diabetes
has been defined and measured in three
ways in clinical research: 1) as a syndrome
that meets DSM-IV criteria for major de-
pressive disorder (MDD) usually assessed
by a well-standardized, semistructured
interview (e.g., Composite International
Diagnostic Interview [11]); 2) as depres-
sive symptoms assessed by general symp-
tom inventories (e.g., Beck Depression
Inventory [12] or Center for Epidemio-
logical Studies-Depression Scale [CES-D]
[13]) (counts of the number and/or sever-
ity of depressive symptoms as assessed by
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an instrument that documents mood
states but does not link or associate each
with particular events or life circum-
stances, such as diabetes); and 3) as dis-
tress linked specifically to diabetes and its
management assessed by diabetes-
specific distress questionnaires (e.g.,
Problem Areas in Diabetes Scale [14] or
Diabetes Distress Scale [15]). Unfortu-
nately, distinctions among these three po-
tentially different affective conditions
often have not been made clear across
studies; the term “depression” has often
been used to refer to all three, and a large
number of scales and measures have been
used inconsistently to measure each.
Consequently, a lack of clarity regarding
what was being assessed and differences
in the types of measures used have exac-
erbated the problems of exploring the re-
lationship between depression and
glycemic control.
In a three-wave, longitudinal, obser-
vational study of 506 type 2 diabetic pa-
tients, we sought to clarify the differences
and similarities among these three ap-
proaches to defining and measuring de-
pression and their interrelationships with
glycemic control by examining the sys-
tematic covariation of all three with gly-
cemic control in the same cross-sectional,
prospective, and time-varying analyses.
Using well-established measures of each,
our goals were to clarify issues of defini-
tion to provide clearer targets for the de-
velopment of appropriate interventions.
Three research questions were posed:
First, what is the concurrent, indepen-
dent relationship between each of these
three affective constructs and A1C (cross-
sectional analysis)? Second, does the level
or occurrence of any or all of these three at
initial assessment significantly predict
changes in A1C over subsequent study
waves (prospective analysis). Third, do
fluctuations in any or all of these three
correspond with fluctuations in A1C over
study waves (time-varying analysis)? In
addition, we explored the impact of pa-
tient demographics, diabetes status, med-
ications, self-management behaviors, and
extradisease stressors in each analysis.
RESEARCH DESIGN AND
METHODS— Patients were identified
from registries from four urban commu-
nity-based medical groups and four dia-
betes education settings. After physician
permission was obtained, patients re-
ceived a letter, a screening phone call, and
then a personal visit from a project staff
member to introduce them to the study
and collect informed consent. Inclusion
criteria were type 2 diabetes, age 21–75
years, ability to read and speak English or
Spanish fluently, no severe diabetes com-
plications (undergoing dialysis or legally
blind), and no diagnosis of dementia or
psychosis. At the initial assessment (T1)
patients participated in a 1.5-h visit that
included questionnaires, physical mea-
surements and interviews, a 150-item
mail-back questionnaire, and forms for a
visit to a local laboratory for collection of
blood and urine specimens. Patients were
contacted again 9 (T2) and 18 (T3)
months later, at which time the same as-
sessments were repeated. The mean be-
tween-wave interval was 9.1 months.
Patients who met the criteria for affective
or anxiety disorder and who were not be-
ing treated were referred to their physi-
cian. Approval was received by the
institutional review board at the Univer-
sity of California, San Francisco and at
each participating facility.
The dependent variable for all analy-
ses was A1C. Patient demographics in-
cluded sex, self-identified ethnicity
(white or nonwhite), age, education
(years), and time since diagnosis (years).
Also collected were use of insulin (yes or
no), BMI, number of complications, and
number of comorbidities. Diet and exer-
cise were measured by the Summary of
Diabetes Self-Care Activities, which has
demonstrated reliability and sensitivity to
change over time (16). Patients reported
the number of days in the past week they
followed their diet or exercise plans. Life
stress unrelated to diabetes was assessed
by the Negative Life Events Scale (17),
based on a list of 22 potential stressful
events, such as death of a friend or being a
crime victim. Life context stressors have
been shown to affect glucose levels (18)
and self-management behavior (19), thus
potentially affecting glycemic control
over time.
MDD was assessed by the CIDI (11), a
frequently used, reliable, structured diag-
nostic interview based on DSM-IV crite-
ria. The time frame for MDD at T1 was
occurrence during the past year and
“since we saw you last” was used for T2
and T3. Depressive symptoms were as-
sessed by the CES-D (13), a frequently
used, reliable, continuous scale that as-
sesses the number of days during the last
week that each of 20 free-standing de-
pressive symptoms occurred. Diabetes
distress was assessed by the DDS (15), a
continuous scale (  0.93) that assesses
each of 17 items across six levels of sever-
ity of emotional, regimen-related, social,
and medical care distress related to diabe-
tes and its management.
Data analysis
We used multilevel modeling (MLM) (20)
to assess the independent relationship
among demographics, diabetes status,
stress, self-management, the three affec-
tive variables, and baseline level and
change in A1C across three assessments,
covering 18 months. MLM accounts for
correlations among nested responses in
repeated-measures designs and maxi-
mizes efficiency by including all available
information for each respondent, even if
an assessment is missed. A distinctive fea-
ture of MLM is that it allows for an esti-
mation of between-person and within-
person models to test whether the effect of
a predictor on an outcome varies by pa-
tient subgroup. Finally, it accommodates
tests of time-varying covariates, reflecting
how subgroups of variables change to-
gether over time.
We evaluated two preliminary mod-
els to provide information about the vari-
ability of A1C. An unconditional means
model partitioned the total variance of
A1C across people and waves into two
pieces: the between-person and the with-
in-person variance. An unconditional
growth model further partitioned the
within-person variance into two pieces:
the estimated variance of the slope of
change in A1C over time and other
changes in A1C not related to time. We
then examined three analytic models.
First, we evaluated how baseline predic-
tors were related to baseline levels of A1C
(cross-sectional analyses) and second,
how these predictors were related to lin-
ear change in A1C over time (prospective
analyses). Third, we also explored a set of
time-varying covariates: how changes in a
predictor over time were related to
changes in A1C over time. These models
corresponded to the three research ques-
tions posed.
Time was centered at T1 and coded in
years (0, 0.75, and 1.5). The natural log of
A1C was used to normalize the residuals.
Baseline predictor variables were cen-
tered at their grand means so that the es-
timates of the intercept and time were
interpretable. There was no evidence of
multicollinearity among the predictors.
Estimates were obtained with Proc Mixed
(SAS version 9.2) using full maximum
likelihood and robust SEs (20). We also
examined nonlinearities among the con-
tinuous variables and assessed a series of
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interactions among the three affective
variables, as well as between each with
age, sex, time with diabetes, and insulin
use: all were nonsignificant. We also ex-
plored the impact of use of psychotropic
medication in all models: again, all were
nonsignificant. At each stage, residuals
were examined for normality and
heterogeneity.
RESULTS
Preliminary analyses
Telephone screening identified 640 eligi-
ble individuals, and 506 of these com-
pleted the T1 assessment (79.0%) (Table
1). No significant differences were re-
corded between those who refused ini-
tially and those who participated on all
major study variables.
Approximately 81% of patients com-
pleted all three study waves, 21 (4.2%)
missed T2 only, 40 (7.9%) missed T3
only, and 34 (6.7%) missed both T2 and
T3. Patients who completed all three
waves were compared with patients who
missed one or two waves on 28 variables.
Those who missed a wave more often
spoke Spanish than English (r  0.09,
P 0.04) and had diabetes longer. Those
with MDD, high depressive affect, or dia-
betes distress did not miss a wave or drop
out more often than those without these
conditions.
Concurrent relationships
All three affective variables were signifi-
cantly intercorrelated at T1, although the
relationship between CES-D and DDS
(r 0.48, P 0.001) was notably higher
than the relationship of these two vari-
ables with MDD (MDD with CES-D, r 
0.29, P  0.001; MDD with DDS, r 
0.15, P 0.001). Both CES-D (r 0.14;
P  0.002) and DDS (r  0.17; P 
0.001) were significantly correlated with
A1C, whereas MDD was not (r0.05).
Of the 12 other variables in the multivar-
iate model (Table 2), 8 displayed signifi-
cant zero-order correlations with A1C:
race/ethnicity (r  0.19, P  0.001),
age (r  0.08, P  0.05), education
(r0.16, P 0.001), time with diabe-
tes (r 0.27, P 0.001), insulin use (r
0.29, P  0.001), complications (r 
0.17, P  0.001), life events (r  0.13,
P  0.01), and diet (r  0.09, P 
0.05).
Table 2 shows the cross-sectional re-
lationships between each variable in the
model and A1C at T1, with controls for all
other variables. Patients who were non-
white, had more comorbidities, had dia-
betes longer, and were receiving insulin
had higher A1C at T1 than those who
were white, had few comorbidities, had
diabetes a shorter time, and were not re-
ceiving insulin. Of the three affective vari-
ables, however, a significant positive
relationship with A1C was found only for
DDS but not for MDD or CES-D. Not
shown are models in which each of the
three affective variables was entered into
separate equations individually. Only
DDS reached significance (P  0.004);
MDD and CES-D did not. The results
were replicated in analyses with T2 and
T3 cross-sectional data.
Prospective analyses
These analyses used T1 variables to pre-
dict change in A1C over time. Although
the average change in A1C over time was
not significantly different from zero for
the sample as a whole, there was signifi-
cant within-person variation in A1C
change over time: slopes for 95% of the
sample ranged from 0.122 to 0.128,
with some decreasing and some increas-
ing systematically over time. Table 2
shows that three T1 variables indepen-
dently predicted change in A1C over
time: older patients and those having di-
abetes longer displayed significantly
greater decreases in A1C over time than
younger patients and those with a more
recent diagnosis of diabetes. Also, those
with more comorbidities at T1 displayed
greater increases in A1C over time than
those with fewer comorbidities. None of
the three affective variables significantly
predicted change in A1C over time. Also,
Table 2—Cross-sectional and prospective models predicting glycemic control (A1C)
Cross-sectional model Prospective model
Coefficient (b) P Coefficient (b) P
Baseline/time 1.964 0.01 0.003 0.56
Sex (1  female; 0  male) 0.004 0.81 0.003 0.78
Race (1  white; 0  non-white) 0.052 0.001 0.001 0.92
Age (years) 0.001 0.36 0.001 0.02
Education (years) 0.004 0.08 0.001 0.42
Time since diagnosis (years) 0.005 0.001 0.002 0.03
Insulin (1  yes; 0  no) 0.096 0.001 0.001 0.94
BMI 0.001 0.17 0.001 0.73
No. complications 0.006 0.30 0.005 0.24
No. comorbidities 0.007 0.02 0.004 0.05
No. stressful events 0.004 0.07 0.001 0.80
Diet 0.006 0.37 0.004 0.34
Exercise 0.003 0.36 0.001 0.63
MDD 0.027 0.25 0.010 0.55
DDS 0.026 0.006 0.005 0.49
CES-D 0.001 0.89 0.001 0.89
Residual covariance components
Baseline 0.019 0.01
Time 0.004 0.01
Within-person 0.007 0.01
Covariance 0.001 0.14
Data are unstandardized regression coefficients. The cross-sectional model uses data from T1; the prospec-
tive model uses T1 predictors of change in A1C over time.
Table 1—Sample description (n  506)
Sex (male/female) 218 (43)/288 (57)
Age (years) 57.8  9.8
Education (years) 14.7  3.3
Family income ($1,000) 52.8  36.3
BMI (kg/m2) 32.7  7.7
Psychotropic medications 105 (20.8)
No. of comorbidities 3.9  2.5
No. of complications 0.8  1.2
Years with diabetes 8.1  7.5
Insulin use 76 (15.0)
Race/ethnicity
Asian American 85 (16.8)
African American 104 (20.4)
Hispanic 99 (19.6)
Non-Hispanic white 186 (36.8)
Other 33 (6.5)
A1C 7.2  1.44
DDS 2.1  1.0
CES-D 11.0  10.5
MDD 54 (10.7)
Data are means  SD or n (%).
Fisher and Associates
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none of the three reached significance
when each was entered individually into
separate regression models.
Time-varying relationships
These analyses added sets of time-varying
covariates to the previous model to exam-
ine whether change in each characteristic
was independently related to change in
A1C over time. We included patient sex,
ethnicity, age, education, and time with
diabetes as covariates in these analyses
but did not explore their time-varying re-
lationships with A1C because these vari-
ables were viewed as being relatively fixed
over time. These analyses provided statis-
tical information only about the degree of
time-concordant association between
changes in a characteristic and changes in
A1C over time; they did not provide in-
formation about the causal linkages be-
tween the two.
The first columns of Table 3 show the
coefficients for the time-varying associa-
tions among the three affective variables
and A1C, with all other variables entered
as controls. Only DDS, but not MDD or
CES-D, displayed a significant time con-
cordant association with A1C (b 0.024,
P  0.001). The right-hand columns of
Table 3 show the independent time-
varying relationships for all variables in
the model. Again, only DDS displayed a
significant time concordant relationship
with A1C (b 0.023, P 0.001). When
each of the affective variables was entered
individually into separate models, only
DDS reached significance (P  0.001).
CONCLUSIONS— Ours is one of
the few observational, noninterventional
studies that explored both the cross-
sectional and longitudinal relationships
of MDD, depressive symptoms, and dia-
betes distress with glycemic control using
well-established scales that specifically
addressed each of the three affective con-
structs. With a comprehensive battery of
controls in the models, we found no sta-
tistically significant cross-sectional, pro-
spective, or time-concordant relationship
between MDD and A1C or between de-
pressive symptoms and A1C. Only dis-
tress specifically linked to diabetes
displays both cross-sectional and time-
varying longitudinal relationships with
A1C. Distress, however, also shows no
prospective relationship with A1C.
Congruent with prior research, we
find no evidence of a statistically signifi-
cant relationship between MDD and gly-
cemic control or between depressive
symptoms and glycemic control (8,21). A
similar finding is provided by a recent
study with both type 1 and type 2 diabetic
patients that showed that improvements
in depressive symptoms after cognitive
behavior therapy were not associated
with changes in A1C (7). Thus, in both
prospective studies, in which changes in
MDD or in depressive symptoms occur
after behavioral or pharmacological inter-
vention, and in noninterventional stud-
ies, in which changes in symptoms or
MDD are recorded over time, we see little
or no concomitant changes in glycemic
control. We conclude from these studies
that the association between MDD and
depressive symptoms with glycemic con-
trol is most likely modest at best and may
be an artifact of the complex pattern of
frequently uncontrolled interrelation-
ships often found among a host of mood,
diabetes status, treatment, behavioral,
and life context variables (22). These are
illustrated by the T1 zero-order correla-
tional findings reported above. If MDD
and glycemic control are linked, it may be
that depressive states have to be of suffi-
cient intensity and duration to demon-
strate the effect, or it may be that there are
multiple pathways between MDD and de-
pressive symptoms with glycemic control
and that they operate differently for dif-
ferent patients under different life con-
texts. If a causal link does exist, most
likely there is no single, easily identified
common pathway.
In contrast, we find that emotional
distress specifically tied to diabetes and
its management displays both cross-
sectional and time-concordant relation-
ships with A1C. These results do not
necessarily imply a causative relationship
between the two, especially because no
significant prospective linkages between
DDS and A1C were found. We suspect
that each most likely influences the other
over time, suggesting a bidirectional rela-
tionship (5) within the context of other
co-occurring diabetes and life context
variables (22). For example, for some pa-
tients, high disease distress can influence
self-management and medication adher-
ence with subsequent effects on glycemic
control, and for other patients, poor con-
trol can lead to distress, which can influ-
ence disease management (23). This
formulation of the relationship between
diabetes distress and glycemic control
does not assume the direct involvement of
any physiological process but instead em-
phasizes the ongoing negative subjective
experience of emotional distress around
the management of a significant chronic
condition that has implications for ongo-
ing disease-related behavior, motivation,
self-efficacy, and problem solving. Similar
results have been reported with other
chronic diseases as well (24,25).
It is also likely that some depressive
symptoms partly reflect the negative emo-
tional experience that surrounds disease-
specific distress (26). This factor may
explain the significant association be-
tween CES-D and DDS (r  0.48), cou-
pled with the finding that only DDS, but
not CES-D, displays both independent
cross-sectional and time concordant rela-
tionships with A1C. Thus, symptom in-
ventories, such as CES-D, may tap into
the negative emotional component of di-
abetes-specific distress.
In an effort to clarify and be more pre-
cise about what has been called depres-
sion in diabetes, it may be helpful
Table 3—Time-covarying models predicting change in glycemic control over time (A1C)
Model with three affective
time-varying covariates Complete model
Coefficient (b) P Coefficient (b) P
Insulin (1  yes; 0  no) 0.026 0.25
BMI 0.006 0.10
No. complications 0.005 0.41
No. comorbidities 0.001 0.62
No. stressful events 0.001 0.87
Diet 0.002 0.69
Exercise 0.002 0.39
MDD 0.018 0.17 0.017 0.20
DDS 0.024 0.001 0.023 0.001
CES-D 0.001 0.151 0.001 0.18
Data are unstandardized regression coefficients. Patient sex, race, age, education, and time since diagnosis
also were included in the model.
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clinically to consider and assess two rela-
tively common conditions: MDD and di-
abetes-specific distress. For example, it
has been shown that most individuals
who are distressed about their chronic
disease are not clinically depressed (27),
that distress can be conceptually and em-
pirically differentiated from depression
and depressive symptoms, and that dis-
tress has stronger linkages with common
psychological, behavioral, and social fac-
tors than clinical depression or depressive
symptoms (26,28). Diabetes distress is
about twice as prevalent as MDD in this
population, is more persistent over time
than MDD and high depressive symp-
toms, and is significantly and indepen-
dently associated with a host of diabetes-
related variables, e.g., BMI, complications,
comorbidities, and self-management be-
haviors (26). Both MDD and diabetes dis-
tress are serious, treatable, and worthy of
clinical concern.
There are several limitations to our
findings. First, our use of a diverse com-
munity sample led to somewhat small
subsamples of patients with defined af-
fective conditions. Although we had
sufficient statistical power to address
the research questions posed, larger
stratified samples might permit more
comprehensive subgroup analyses. Sec-
ond, we measured change across three
assessments totaling 18 months. Stud-
ies with more frequent assessments that
continue for a longer duration may yield
additional findings. Third, the failure to
observe a relationship between MDD
and glycemic control may be partially
due to a statistical issue: MDD is a di-
chotomous variable, whereas DDS,
CES-D, and A1C are continuous vari-
ables, and correlations between contin-
uous variables generally will be higher
than correlations between a continuous
variable and a binary variable. This is a
problem inherent in a diagnostic ap-
proach and may argue for the use of
more dimensional measures, which are
generally more powerful. Fourth, some
of the findings from the time-covarying
analyses may have been influenced by
patient knowledge of their A1C level.
Future researchers might explore the ef-
fects of this variable further. In contrast,
the strengths of the study include a di-
verse community-based sample with
high rates of participation and reten-
tion, and the use of sophisticated data
analytic procedures that permit maxi-
mum flexibility and power in analyzing
both cross-sectional and longitudinal
data.
In summary, we found no cross-
sectional, prospective, or time-concordant as-
sociations between MDD and depressive
symptoms with glycemic control,
whereas significant cross-sectional and
time-concordant relationships were
found between diabetes distress and gly-
cemic control. Given the linkages be-
tween diabetes distress and a host of
diabetes management variables, we em-
phasize the importance of exploring fur-
ther with empirical studies the interactive
relationship between diabetes distress
and glycemic control, screening for both
MDD and disease-related distress in the
clinical setting, and development of inter-
ventions for nondepressed but distressed
patients with diabetes.
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Luke’s Diabetes Education Center, St.
Mary’s Medical Center, and University of
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